Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

Clinical trial NCT00584298 · COMPLETED

Trial details

NCT number: NCT00584298
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2008-01-01
Primary completion: 2009-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.